FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Sees Significant Drop in Short Interest

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 31,120 shares, a decline of 54.8% from the September 30th total of 68,908 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average trading volume of 20,314 shares, the days-to-cover ratio is presently 1.5 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Blue Bell Private Wealth Management LLC acquired a new stake in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 3,399 shares of the company’s stock, valued at approximately $163,000.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Down 0.9%

BATS DOCT opened at $48.08 on Friday. The stock has a market capitalization of $395.70 million, a PE ratio of 24.90 and a beta of 0.37. FT Vest U.S. Equity Deep Buffer ETF – October has a 12-month low of $42.76 and a 12-month high of $48.61. The company has a 50 day moving average price of $48.01 and a two-hundred day moving average price of $46.16.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.